Ravoquix 0,5 Mg & 1 Mg 0,5 mg & 1 mg FC tablet
PDF Leaflet Revision Date: 26 NOV 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Aid to smoking cessation in patients committed to stop smoking.
Dosage (summary)
1 mg twice daily after a 1-week titration: 0.5 mg once daily (Days 1-3), 0.5 mg twice daily (Days 4-7), 1 mg twice daily (Days 8-12).
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly
- Paediatric population
Pregnancy & Breastfeeding
Not recommended in pregnancy; safety during lactation not established.
Key Drug Interactions
- Warfarin
- Bupropion
- Nicotine replacement therapy
- Cimetidine
Contraindications
- Hypersensitivity to varenicline or excipients
Common side effects
- Nausea
- Insomnia
- Headache
- Dizziness
- Rash
Counselling Points
- Monitor for neuropsychiatric symptoms
- Avoid abrupt discontinuation
- Caution with alcohol consumption
Serious warnings
- Neuropsychiatric symptoms
- Seizures
- Serious skin reactions
- Cardiovascular effects
Important Disclaimer
The Ravoquix 0,5 Mg & 1 Mg 0,5 mg & 1 mg FC tablet professional information leaflet below is the property of Hetero Drugs South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
